⏱️ Yields just hit a 19-year high

KEY TAKES

• Hot PMI plus an oil rebound re-priced the 10-year to ~5.05% — highest since 2007. SPY −0.63%, QQQ −0.86%, DIA −0.58%, IWM −1.62% (~1:25 CT).
• Dated board: ARTL ART27.13 obesity patent (GlobeNewswire 07:33 ET). FSLY Street notes after investor-day. GRAL Galleri AdCom today.
• Vienna “cartel” meeting names one overlooked ticker you can fight back with (From Brownstone Research)
• Park BENF (Heppner/HCLP cut, Reg SHO micro), WHLR (chart-only), VSA halt, MSS no wire. Empty percent.
• Thursday open is GRAL’s tell after today’s Galleri AdCom — not today’s percent leaders.

Duration got expensive. Hot S&P Global PMI (composite ~58.4, a five-year-plus high) plus Brent back near $101 pushed the 10-year Treasury to ~5.05% — the highest since 2007. Motley Fool midday (12:54 ET) framed it clean: stocks slip as Treasury yields hit a 19-year high. Prints ~1:25 p.m. CT: SPY 768.51 (−0.63%), QQQ 741.05 (−0.86%), DIA 515.00 (−0.58%), IWM 282.56 (−1.62%). Mid-session tape. Not the official close.

Rate-sensitive growth and small-caps paid that duration bill. When the 10-year jumps, long-duration cash flows get marked down — QQQ took it, IWM took it harder at −1.62%. That is the session: a hotter activity print and an oil bid re-priced the front end, so liquid duration trades got cheaper while the percent board printed noise.

Artelo is the dated name on the gainer list. GlobeNewswire 07:33 ET / The Fly 07:36 ET: a provisional patent covering ART27.13 for obesity alone and with GLP-1 agonists, with nonclinical ~40% weight loss in combo with semaglutide. ARTL $9.37, +125.8%, ~18.6M shares, plus a midday imbalance halt. Fastly is the liquid quality aside on a red QQQ day: $29.24, +12.1%, ~13.5M, on post-investor-day PT raises (Freedom $37, DA Davidson $23, BofA $22 Underperform, RBC). Park BENF, WHLR, VSA, and MSS — Heppner/HCLP micro, a chart-only REIT, a halt with no wire, and a volume spike with no same-day PR. Empty percent until a clean follow-through.

TODAY'S TOP 5

1 · BENF+408.9% — $2.74 | Nasdaq — cut HCLP debt / Heppner equity (8-K / Fly / SA). Reg SHO micro. Noise.

2 · WHLR+165.8% — $4.97 | Nasdaq — IBN Spotlights volume-chart only; 52-week lows. No same-day preferred PR. Noise.

3 · ARTL+125.8% — $9.37 | Nasdaq — GlobeNewswire 07:33 ET ART27.13 obesity patent, combo with GLP-1.

4 · VSA+87.9% — $3.72 | Nasdaq — halt (code 02) ~13:48 ET. No same-day preferred PR. Noise.

5 · MSS+40.4% — $2.19 | Nasdaq — no same-day preferred PR; prior convert cleanup / delayed 10-K. Noise.

THE SIGNAL

Hot PMI plus the oil rebound re-priced duration. Growth and small-caps got cheaper; the 10-year at ~5.05% is the constraint. Trade the dated patent (ARTL) and the liquid Street notes (FSLY). Park BENF, WHLR, VSA, and MSS until a preferred wire shows. Thursday’s open on GRAL is the next tell after today’s Galleri AdCom.

Wrong if: 10y yields ease back under ~4.95% into the close and QQQ recovers while ARTL fails to hold double-digit gains on volume.

HEADLINE OF THE DAY

“Stock Market Midday, Sept. 23: Stocks Slip as Treasury Yields Hit 19-Year High”

Motley Fool via QuoteMedia | Sep 23, 2026 12:54 ET

ONE TO WATCH

GRAL · Galleri FDA advisory panel is Wed Sep 23, 2026. UBS (9/22) flagged a more focused FDA review ahead of the panel; Baird took the PT to $118 (9/22). Thursday’s open is the tell — not a recap of ARTL or FSLY.

Market Signal Report
powered by StocksToTrade

Signal over noise. 19-year yield high. Dated wires only.

HANDPICKED FOR YOU